The efficacy of diphenhydramine in the prevention and treatment of methomyl
-induced toxicosis was evaluated in female rats. Diphenhydramine at 10 and
20 mg/kg subcutaneously (s.c.) given immediately after methomyl increased t
he LD,, of methomyl (6.29 mg/kg intraperitoneally (i.p.)) in the rats by 71
and 75% respectively. Diphenhydramine at 20 mg/kg s.c. given immediately a
fter methomyl (6 mg/kg i.p.) decreased the occurrence of cholinergic signs
of toxicosis, and prevented convulsions, gasping and death by 100% in compa
rison with the control (methomyl-saline) group. Diphenhydramine administrat
ion at 2.5, 5 and 10 mg/kg s.c. 20 min before methomyl (8 mg/kg i.p.) signi
ficantly and dose-dependently decreased the number of convulsion episodes i
n rats in comparison with the control group. This effect was similar to tho
se of atropine and diazepam pretreatments at 20 mg/kg s.c. Diphenhydramine
and atropine at 20 mg/kg i.p. given 5 min after the methomyl administration
(8 mg/kg i.p.) were close to each other in reducing the signs of cholinerg
ic toxicity as well as the severity of toxicosis induced by methomyl in rat
s. Methomyl at 4 and 8 mg/kg i.p, significantly decreased erythrocyte (40 a
nd 43%) and plasma (23 and 31%) cholinesterase activities in comparison wit
h the control group. Diphenhydramine (10 mg/kg s.c.) injected 15 min before
methomyl significantly decreased the inhibitory effect of methomyl (4 and
8 mg/kg i.p.) on erythrocyte cholinesterase to 17 and 27%, respectively. Th
e inhibitory effect on plasma cholinesterase was not affected by the diphen
hydramine pretreatment. The data suggest that diphenhydramine could be of t
herapeutic value in reducing the toxic effects of methomyl. (C) 1999 Elsevi
er Science B.V. All rights reserved.